Difference between revisions of "Part:BBa K2738006"
Line 9: Line 9:
  
 
Using homology modelling, we obtained the structure of ferritin-ovispirin fusion monomer protein. Using homology alignment, we were able to reconstruct the assembled ferritin-ovispirin monomer into the multimeric star-shaped construct.   
 
Using homology modelling, we obtained the structure of ferritin-ovispirin fusion monomer protein. Using homology alignment, we were able to reconstruct the assembled ferritin-ovispirin monomer into the multimeric star-shaped construct.   
−
<img scr="https://static.igem.org/mediawiki/2018/f/f8/T--Paris_Bettencourt--c6_monomer.gif">
+
<img src="https://static.igem.org/mediawiki/2018/f/f8/T--Paris_Bettencourt--c6_monomer.gif">
 
Monomer
 
Monomer
  
−
<img scr="https://static.igem.org/mediawiki/2018/f/fc/T--Paris_Bettencourt--c6_assemble.gif">
+
<img src="https://static.igem.org/mediawiki/2018/f/fc/T--Paris_Bettencourt--c6_assemble.gif">
 
Assembly
 
Assembly
  
Line 19: Line 19:
 
The ferritin-ovispirin fusion protein was produced via cell-free expression system. The expression was verified by SDS gel as shown in the figure below.  
 
The ferritin-ovispirin fusion protein was produced via cell-free expression system. The expression was verified by SDS gel as shown in the figure below.  
 
<div class="text1 img">  
 
<div class="text1 img">  
−
<img scr="https://static.igem.org/mediawiki/2018/f/fc/T--Paris_Bettencourt--BBa_K2738006.png">
+
<img src="https://static.igem.org/mediawiki/2018/f/fc/T--Paris_Bettencourt--BBa_K2738006.png">
 
Figure 2. Cell free expression and purification of Ferritin-ovispirin-StarCore
 
Figure 2. Cell free expression and purification of Ferritin-ovispirin-StarCore
 
</div>
 
</div>
Line 30: Line 30:
 
The results indicate that the ferritin-ovispirin StarCore has the MIC activity at 3 ug/ml for both E coli and B subtilis. Moreover, at 7.3 uM it also affects their growth kinetics to a significant extent indicating bactericidal activity. The antibacterial activity of ferritin-ovispirin StarCore is comparable to ovispirin at its MIC concentration (5 uM) alone as shown in the figure.  
 
The results indicate that the ferritin-ovispirin StarCore has the MIC activity at 3 ug/ml for both E coli and B subtilis. Moreover, at 7.3 uM it also affects their growth kinetics to a significant extent indicating bactericidal activity. The antibacterial activity of ferritin-ovispirin StarCore is comparable to ovispirin at its MIC concentration (5 uM) alone as shown in the figure.  
 
<div class="text1 img">
 
<div class="text1 img">
−
<img scr="https://static.igem.org/mediawiki/2018/4/4d/T--Paris_Bettencourt--BB_006.png">
+
<img src="https://static.igem.org/mediawiki/2018/4/4d/T--Paris_Bettencourt--BB_006.png">
 
</div>
 
</div>
  
Line 39: Line 39:
 
Control:  
 
Control:  
 
<div class="text1 img">
 
<div class="text1 img">
−
<img scr="https://static.igem.org/mediawiki/2018/f/f6/T--Paris_Bettencourt--control_bsub.gif">
+
<img src="https://static.igem.org/mediawiki/2018/f/f6/T--Paris_Bettencourt--control_bsub.gif">
 
</div>
 
</div>
  
 
Ovispirin+Ferritin:  
 
Ovispirin+Ferritin:  
 
<div class="text1 img">
 
<div class="text1 img">
−
<img scr="https://static.igem.org/mediawiki/2018/4/44/T--Paris_Bettencourt--OV1_-_bsub.gif">
+
<img src="https://static.igem.org/mediawiki/2018/4/44/T--Paris_Bettencourt--OV1_-_bsub.gif">
 
</div>
 
</div>
  
Line 50: Line 50:
  
 
<div class="text1 img">
 
<div class="text1 img">
−
<img scr="https://static.igem.org/mediawiki/2018/1/17/T--Paris_Bettencourt--liposome_c6.png">  
+
<img src="https://static.igem.org/mediawiki/2018/1/17/T--Paris_Bettencourt--liposome_c6.png">  
 
</div>
 
</div>
  
 
Figure 1. Mammalian liposome leakage induced by ferritin-ovispirin StarCore (A) and the kinetics of liposome leakage (B). Ovispirin (5 uM) and ferritin-ovispirin (3 uM) are used at their MIC concentration obtained from previous results.  
 
Figure 1. Mammalian liposome leakage induced by ferritin-ovispirin StarCore (A) and the kinetics of liposome leakage (B). Ovispirin (5 uM) and ferritin-ovispirin (3 uM) are used at their MIC concentration obtained from previous results.  
−
<img scr="https://static.igem.org/mediawiki/2018/1/17/T--Paris_Bettencourt--liposome_c6.png">
+
<img src="https://static.igem.org/mediawiki/2018/1/17/T--Paris_Bettencourt--liposome_c6.png">
  
 
To test the biocompatibility of the StarCores with mammalian membrane, we performed liposome leakage assay. Ovispirin alone lyses the liposome indicating damage to mammalian cell membrane. Ferritin-ovispirin has a reduced effect on the liposome leakage indicating an improvement in biocompatibility towards mammalian cell membrane. The Starcore ferritin-ovispirin has a safer profile in terms of membrane activity as compared to ovispirin alone at their respective MIC concentration.
 
To test the biocompatibility of the StarCores with mammalian membrane, we performed liposome leakage assay. Ovispirin alone lyses the liposome indicating damage to mammalian cell membrane. Ferritin-ovispirin has a reduced effect on the liposome leakage indicating an improvement in biocompatibility towards mammalian cell membrane. The Starcore ferritin-ovispirin has a safer profile in terms of membrane activity as compared to ovispirin alone at their respective MIC concentration.

Revision as of 05:56, 9 November 2018


Ovispirin fused to N-ter of Ferritin protein Part: BBa_K2738006 (Ferritin-ovispirin) Description We aimed to fuse antimicrobial peptides to self-assembling multimeric proteins giving us star-shape antimicrobial peptides called StarCores. The StarCore described here is a result of the fusion of Ferritin (self-assembling protein) to ovispirin (antimicrobial peptide) via golden-gate assembly. The fusion protein expression is regulated by T7-promoter.

Ferritin is a universal intracellular protein produced by almost all living organisms, including algae, bacteria, higher plants, and animals. Ferritin is a globular protein complex consisting of 24 protein subunits forming a nanocage. Ovispirin is an alpha-helical antimicrobial peptide derived from derived SMAP29 peptide.It was found to inhibit several antibiotic-resistant bacterial strains.

Using homology modelling, we obtained the structure of ferritin-ovispirin fusion monomer protein. Using homology alignment, we were able to reconstruct the assembled ferritin-ovispirin monomer into the multimeric star-shaped construct. <img src="T--Paris_Bettencourt--c6_monomer.gif"> Monomer

<img src="T--Paris_Bettencourt--c6_assemble.gif"> Assembly

Results: Expression verification The ferritin-ovispirin fusion protein was produced via cell-free expression system. The expression was verified by SDS gel as shown in the figure below.

<img src="T--Paris_Bettencourt--BBa_K2738006.png"> Figure 2. Cell free expression and purification of Ferritin-ovispirin-StarCore


2. MIC and growth curve We determined the MIC of ferritin-ovispirin StarCore to inhibit the growth of E coli and B subtilis (figure A and B). We performed growth curve assay for E coli and B subtilis with and without antimicrobial peptides as shown in figure C and D.

The results indicate that the ferritin-ovispirin StarCore has the MIC activity at 3 ug/ml for both E coli and B subtilis. Moreover, at 7.3 uM it also affects their growth kinetics to a significant extent indicating bactericidal activity. The antibacterial activity of ferritin-ovispirin StarCore is comparable to ovispirin at its MIC concentration (5 uM) alone as shown in the figure.

<img src="T--Paris_Bettencourt--BB_006.png">

3. Dynamic time-lapse imaging of bactericidal cell viability

The following results were obtained by time-lapse microscopy imaging, to study the bactericidal effect of antimicrobial peptides on B subtilis viability. Here we can observe that the presence of antimicrobial peptide proves to be toxic for the growing B subtilis which supports our growth curve data and MIC data.

Control:

<img src="T--Paris_Bettencourt--control_bsub.gif">

Ovispirin+Ferritin:

<img src="T--Paris_Bettencourt--OV1_-_bsub.gif">

4. Biocompatibility towards mammalian cell membrane

<img src="T--Paris_Bettencourt--liposome_c6.png">

Figure 1. Mammalian liposome leakage induced by ferritin-ovispirin StarCore (A) and the kinetics of liposome leakage (B). Ovispirin (5 uM) and ferritin-ovispirin (3 uM) are used at their MIC concentration obtained from previous results. <img src="T--Paris_Bettencourt--liposome_c6.png">

To test the biocompatibility of the StarCores with mammalian membrane, we performed liposome leakage assay. Ovispirin alone lyses the liposome indicating damage to mammalian cell membrane. Ferritin-ovispirin has a reduced effect on the liposome leakage indicating an improvement in biocompatibility towards mammalian cell membrane. The Starcore ferritin-ovispirin has a safer profile in terms of membrane activity as compared to ovispirin alone at their respective MIC concentration.

References: Ovispirin obtained from DRAMP database: DRAMP03826 Ferritin obtained from RCSB. PDB number: 4XGS Star shaped antimicrobial peptides : 10.1038/NMICROBIOL.2016.162


Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]